Potent inhibitors of neuraminidase, 3,4-didehydro-4-deoxysiastatin B, 4-deoxysiastatin B and N-[(S and 7?)-l ,2-dihydroxypropyl] derivatives of siastatin B, 3,4-didehydro-4-deoxysiastatin B and 4-deoxysiastatin B have been synthesized by the chemical modifications of siastatin B.
Poly-and multifunctional piperidines isolated from microorganisms and plants are powerful and specific glycosidase inhibitors, and they have the potential to produce a number of kinds of beneficial therapeutic effects such as antihyperglycemic, antiviral and anticancer activity, etc. l)
A multifunctional piperidine, siastatin B (1) which was isolated as an inhibitor of neuraminidase by H. Umezawa et al. 2 ) from a Streptomyces culture, resembles structurally sialic acid (JV-acetylneuraminic acid, 2). After achievement of the total synthesis3~5) and several totally-synthetic analogs,6-7* we have designed potential neuraminidase inhibitors,8'9) transition-state analogs and substrate analogs of neuraminic acid aided by molecular graphics tools. Here we wish to report the syntheses of the inhibitors, 3,4-didehydro-4-deoxysiastatin B (4), 4-deoxysiastatin B (5) and N-[(S and i?)-l,2-dihydroxypropyl] derivatives of siastatin B (13 and 14), 4-deoxysiastatin B (17 and 18) and 3,4-didehydro-4-deoxysiastatin B (21 and 22), and their methyl esters (6, 7, 10, ll, 12, 15, 16, 19 and 20) and amides (8 and 9) by a chemical modification of 1 with the full experimental details (Schemes 1 and 2).8;9) Synthesis In the course of our studies6~10) on the relationships between structure and biological activity of siastatin B, we became interested in the syntheses of rationally designed analogs (4, 5, 13, 14, 17 and 18) of siastatin B able to mimic oxocarbonium ion (3) of neuraminic acid, an intermediate in the reaction catalyzed by neuraminidase ( Fig. 1) , obtained from molecular modeling8'9* using molecular orbital calculations by the AMI method.11* Treatment of 1 with di-terr-butyl dicarbonate (Boc-dimer) at 70°C gave the 3,4-didehydro-4-deoxy Removal of protecting groups (Boc-groups) of 23 with 4m hydrogen chloride in dioxane afforded 3,4-didehydro-4-deoxysiastatin B (4). Hydrogenation of 23 with palladium on carbon yielded in the 4-deoxy compound24 which was converted into 4-deoxysiastatin B (5) by de-protection. Treatment of 23 with methyl iodide afforded 25 which was converted into 3,4-didehydro-4-deoxysiastatin B methyl ester (6) upon removal ofBoc groups. Reduction of25 to 26 followed by acid treatment gave 4-deoxysiastatin B methyl ester (7) . Selective removal of 0-Boc group of 23 with potassium carbonate followed by esterification with methyl iodide gave 28. Ammonolysis of 28 with ammoniacal methanol to the corresponding amide 29, and subsequent removal of Boc-group furnished 3,4-didehydro-4-deoxysiastatin B amide (8) . Reduction of 8 gave 4-deoxysiastatin B amide (9) . Treatment of 1 with Amberlist 15 (H+) in methanol afforded siastatin B methyl ester (10) . Reductive (6, 7, 10, ll, 12, 15, 16, 19 and 20) and the amides (8 and 9) did not inhibit these enzymes. Remarkably, compounds 4, 5, 13 and 17 affected these neuraminidases as strongly as the well-known inhibitor, 2,3-didehydro-2-deoxy-TV-acetylneuraminic acid12) (DDNA, 30). Compounds 4, 5, 17 and 18 inhibited yeast a-glucosidase, and compounds 1, 4 and 5 also affected bovine liver jS-glucuronidase. Compounds 6 and 17 showed weak inhibitory activity against sweet potato /?-amy!ase. Further evaluation of the biological activities of these analogs is in progress.
Experimental
General Methods Melting points were determined with a Yanagimotoapparatus and were uncorrected. IR spectra were determined on a Hitachi Model 260-10 spectrophotometer. Optical rotations were measured with a Perkin-Elmer Model 241 polarimeter. XHNMRspectra were recorded with JEOLJNM-GX400 spectrometer. Chemical shifts are expressed in 3 values (ppm) with tetramethylsilane as an internal standard. Mass spectra were taken by a JEOLJMS-SX102in the FABand SI modes. 
4-Deoxysiastatin B (5)
Compound 24 (30mg) was dissolved in 4m hydrogen chloride in dioxane (0.9ml), and the mixture was allowed to stand at room temperature for 3 hours. Evaporation of the solvent gave an amorphous solid, which was throughly washed with ether. The solid was subjected to preparative TLCon silica gel, developing with a mixture of CHC13-MeOH-cone NH4OH (20: 10: 3), to give a colorless solid (15mg, 4-Deoxysiastatin B Amide (9) The solution of 8 (178mg) in H2O (0.3ml) was stirred with 10% Pd/C (3.1 mg) under atmospheric pressure of hydrogen at room temperature for 3 hours. After filtration, evaporation of the filtrate gave a solid. The solid was subjected to preparative TLCon silica gel, developing with a mixture of CHC13-MeOH-concNH4OH(10: 10: 1), to give 9 as an amorphous solid (131 mg, 74% Siastatin B Methyl Ester (10) The solution of 1 (487mg) in dry MeOH(15ml) was stirred with Amberlist 15 (H+) (500mg) at room temperature overnight. After addition of concNH4OH(pH -8), the resin was filtered off. Evaporation of the filtrate gave a solid, which was subjected to column chromatography on silica gel. Elution with a mixture of CHC13-MeOH-coneNH4OH (20 : 10 : 3) gave a solid. 7V,5-0-Bis(ter£-butoxycarbonyl)-3,4-didehydro-4-deoxysiastatin B (23) To a solution of 1 (1 g) in JV,iV-dimethylformamide (DMF, 38 ml) were added diisopropylethylamine (7.2ml) and Boc-dimer (4.5ml), and the mixture was stirred at 70°C for 5 hours. Evaporation of the solvent gave an oil, which was dissolved in CHC13. The solution was washed with water, dried over MgSO4, and filtered. Evaporation of the filtrate afforded an oil, which was subjected to the column chromatography on silica gel. Elution with a mixture of CHCl3-CH3OH-concNH4OH iV,5-O-Bis(rer^-butoxycarbonyl)-3,4-didehydro-4-deoxysiastatin B Methyl Ester (25) To a solution of 23 (100mg) in DMF (l ml) were added diisopropylethylamine (0.59ml) and Mel (0.086ml), and the mixture was stirred at room temperature for 24 hours. Evaporation of the solvent gave an oil, which was dissolved in CH2C12. The solution was washed with H2O, dried over MgSO4, and filtered. Evaporation of the filtrate gave an oil. The oil was subjected to preparative TLCon silica gel, developing with a mixture ofCHC13-MeOH 
